Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 856583Generated: October 29, 2026

Dimethylformamide → (-)-7-[4-(2-butoxyethoxy)phenyl]-1-cyclopropylmethyl-N-[4-[[[1-propylimidazol-5-yl]methyl]sulfinyl]phenyl]-2,3-dihydro-1H-1-benzazepine-4-carboxamide

https://huagongshe.com/reaction/856583

Reaction equation

Participants

RoleNameHCIDCharge
ReactantDimethylformamideHCID 6228—
ReactantOxalyl chlorideHCID 65578—
Reactant7-[4-(2-butoxyethoxy)phenyl]-1-cyclopropylmethyl-2,3-dihydro-1H-1-benzazepine-4-carboxylic acidHCID 22329210—
Reactant4-[[(1-Propyl-1H-imidazol-5-yl)methyl]sulfinyl]benzenamineHCID 22938610—
SolventWaterHCID 962—
SolventPyridineHCID 1049—
SolventTetrahydrofuranHCID 8028—
Product(-)-7-[4-(2-butoxyethoxy)phenyl]-1-cyclopropylmethyl-N-[4-[[[1-propylimidazol-5-yl]methyl]sulfinyl]phenyl]-2,3-dihydro-1H-1-benzazepine-4-carboxamideHCID 69521927—

Reaction Steps

di-p-toluoyl-D-tartarate 1hydrate (894 mg) was dissolved in ethyl acetate (10 ml) and 1N hydrochloric acid (4.6 ml) to separate the layers. To the aqueous layer was added 25% aqueous solution of potassium carbonate (4.6 ml) and the mixture was extracted with 2-propanol-ethyl acetate (1:4) twice. The organic layer was collected, washed with saturated brine, and dried over magnesium sulfate, and the solvent was distilled off under reduced pressure. To the obtained residue was added tetrahydrofuran, and the solvent was distilled off again under reduced pressure to give (−)-4-(((1-propylimidazol-5-yl)methyl)sulfinyl)aniline. Then, to a solution of 7-[4-(2-butoxyethoxy)phenyl]-1-cyclopropylmethyl-2,3-dihydro-1H-1-benzazepine-4-carboxylic acid (450 mg) in tetrahydrofuran (10 ml) were added one droplet of DMF and oxalyl chloride (0.12 ml) under nitrogen atmosphere and the mixture was stirred for 30 minutes. This solution was added dropwise to a solution of (−)-4-(((1-propylimidazol-5-yl)methyl)sulfinyl) aniline and pyridine (2.17 ml) in tetrahydrofuran (20 ml) at 0° C. under nitrogen atmosphere. The mixture was allowed to be at room temperature, stirred for 3 hours, and water was added to the mixture, and the mixture was extracted with ethyl-acetate. The organic layer was washed with 10% aqueous solution of acetic acid twice, an aqueous solution of saturated sodium bicarbonate twice and saturated brine once, and dried over magnesium sulfate. The solvent was distilled off under reduced pressure, and the residue was separated and purified by basic silica gel column chromatography (ethyl acetate→ethyl acetate:methanol=50:1), to give (−)-7-[4-(2-butoxyethoxy)phenyl]-1-cyclopropylmethyl-N-[4-[[[1-propylimidazol-5-yl]methyl]sulfinyl]phenyl]-2,3-dihydro-1H-1-benzazepine-4-carboxamide (411 mg) (Compound 454) as yellow amorphous.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS07262185B2
Source datasetuspto-grants-2007_08
ORD IDord-5f39ed6f6ae249059a648b7583fd5ea0
Source noteuspto-grants-2007_08